Related references
Note: Only part of the references are listed.Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
Mason W. W. Freeman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
Mason W. Freeman et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2023)
Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers
Mason W. Freeman et al.
HYPERTENSION RESEARCH (2023)
Effects of a low-sodium diet in patients with idiopathic hyperaldosteronism: a randomized controlled trial
Lihua Zhou et al.
FRONTIERS IN ENDOCRINOLOGY (2023)
Aldosterone Synthase Inhibitors and Dietary Interventions: A Combined Novel Approach for Prevention and Treatment of Cardiovascular Disease
Ayoola Awosika et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2023)
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Gracia Fahed et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Essential Hypertension and Oxidative Stress: Novel Future Perspectives
Caterina Franco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis
Sheng-Yin Chen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Luis M. Ruilope et al.
HYPERTENSION (2022)
Aldosterone, Inflammation, Immune System, and Hypertension
Nathanne S. Ferreira et al.
AMERICAN JOURNAL OF HYPERTENSION (2021)
Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension A Randomized Clinical Trial
Susana Lopes et al.
JAMA CARDIOLOGY (2021)
Resistant hypertension: new insights and therapeutic perspectives
Luis M. Ruilope et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
The global epidemiology of hypertension
Katherine T. Mills et al.
NATURE REVIEWS NEPHROLOGY (2020)
The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease
Jessica L. Faulkner et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)
Katrijn Bogman et al.
HYPERTENSION (2017)
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension
Tanja Dudenbostel et al.
HYPERTENSION (2016)
Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors
Marie Briet et al.
HYPERTENSION (2016)
Aldosterone Induces Tissue Inhibitor of Metalloproteinases-1 Expression and Further Contributes to Collagen Accumulation From Clinical to Bench Studies
Chi-Sheng Hung et al.
HYPERTENSION (2016)
Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
Gregory A. Roth et al.
CIRCULATION (2015)
Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis
Anne-Cecile Huby et al.
CIRCULATION (2015)
Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus
Marcondes Alves B. Silva et al.
CLINICAL SCIENCE (2015)
Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus Monkeys
Rainer E. Martin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity
Nicola Schaefer et al.
EUROPEAN HEART JOURNAL (2013)
Study of Aldosterone Synthase Inhibition as an Add-On Therapy in Resistant Hypertension
Adam D. Karns et al.
JOURNAL OF CLINICAL HYPERTENSION (2013)
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy
Christoph D. Schumacher et al.
JOURNAL OF HYPERTENSION (2013)
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice
Faiez Zannad et al.
EUROPEAN HEART JOURNAL (2012)
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways Implications in Diabetes Mellitus-Associated Obesity and Vascular Dysfunction
Ana M. Briones et al.
HYPERTENSION (2012)
Endothelial function and the effects of aldosterone blockade
Isabella Sudano et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2011)
Impact of Leptin-Mediated Sympatho-Activation on Cardiovascular Function in Obese Mice
Eric J. Belin de Chantemele et al.
HYPERTENSION (2011)
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
Hari K. Parthasarathy et al.
JOURNAL OF HYPERTENSION (2011)
Association with Helicobacter pylori infection and ghrelin level in hemodialysis patients
Mitsushige Sugimoto et al.
KIDNEY INTERNATIONAL (2011)
Salt and Aldosterone A Concert of Bad Effects
Maria Czarina Acelajado et al.
HYPERTENSION (2010)
Aldosterone and vascular inflammation
Nancy J. Brown
HYPERTENSION (2008)
Aldosterone impairs baroreflex sensitivity in healthy adults
Kevin D. Monahan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Insulin, renin-aldosterone system and blood pressure in obese people
G Andronico et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet.
FM Sacks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
